Nonetheless, Ezra et al. (48) have shown that a relatively small addition of synthetic, Aβ-free albumin to intraventricular CSF, delivered via an osmotic pump, had measurable effects on Aβ plaque formation as well as several other markers of disease in a mouse model of AD. Here, ALB is linked to Alzheimer disease.